Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-04 | 2024-09 | -0.03 | N/A | N/A | N/A |
2024-08-05 | 2024-06 | -0.04 | 0.01 | 0.05 | 125.00% |
2024-05-07 | 2024-03 | -0.07 | N/A | N/A | N/A |
2024-05-07 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-03-12 | 2023-12 | -0.18 | N/A | N/A | N/A |
2024-03-12 | 2023-12 | -0.18 | -0.12 | 0.06 | 33.33% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-10 | Citigroup | Upgrade | Neutral | Neutral |
2023-03-05 | Canaccord Genuity | Upgrade | Buy | |
2023-03-05 | Credit Suisse | Upgrade | Underperform | |
2022-11-15 | Citigroup | Upgrade | Neutral | |
2022-11-07 | SVB Leerink | Upgrade | Market Perform | |
2022-08-08 | Citigroup | Upgrade | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-02 | CLINTON CHELSEA | Director | 541.84K | Stock Award(Grant) |
2024-01-02 | EDWARDS CARLADENISE ARMBRISTER | Director | 412.25K | Stock Award(Grant) |
2024-08-08 | GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | 1.41M | Purchase |
2024-01-02 | KOUZOUKAS DEMETRIOS L | Director | 465.64K | Stock Award(Grant) |
2024-05-16 | LOENGARD ANNA U | Director | 0.00 | Purchase |
2024-09-12 | REYNOSO JAMIE L. | Officer | 2.75M | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 31.43M | 28.20M | 7.92% |
2023-06-29 | Renaissance Technologies, LLC | 8.85M | 7.94M | 2.23% |
2023-06-29 | Blackrock Inc. | 7.77M | 6.97M | 1.96% |
2023-06-29 | Citadel Advisors Llc | 5.35M | 4.80M | 1.35% |
2023-06-29 | PNC Financial Services Group, Inc. | 5.26M | 4.72M | 1.33% |
2023-06-29 | Millennium Management Llc | 4.65M | 4.17M | 1.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.28M | 9.22M | 2.59% |
2023-06-29 | Vanguard Small-Cap Index Fund | 9.15M | 8.21M | 2.30% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 5.24M | 4.70M | 1.32% |
2023-06-29 | Vanguard Extended Market Index Fund | 4.77M | 4.28M | 1.20% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.70M | 1.44M | 0.43% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 1.37M | 1.16M | 0.34% |
-
$CLOV Do the insiders know something the retail investors don’t, what would be the catalyst for such a huge drop today
-
$CLOV Is it down, yes. Is it down until the doors close, don’t think so. I’ve committed to hodl until December, if there is no progress by then, I will sell everything at a loss. Just hard for me to believe that they can’t sell insurance at wallmart , alphabet can’t program a system that people like, Hillary jr. can’t get pull in the dems, and clover can’t make a lot of money.
-
$CLOV Wondering why has not issued a press release, Doj statement, or anything
-
$CLOV Wondering why has not issued a press release, Doj statement, or anything
-
$CLOV Interesting article on what the SEC is proposing for short transparency
-
$CLOV hindenblimp - If you look at the cost of misinformation vs what your buddies can make off of it, any repercussions are just a slap on the wrist
-
$CLOV I know who is afraid of
Clover, investors in the other insurance rip off insurance companies -
$CLOV This is headed to $11 tomorrow
-
$CLOV me thinks a new trend is developing
-
$CLOV Old mother Hubbard bent over and Clover took over
-
$CLOV “Clover was never a sueeze buy” What they don’t have spell check for the titles? Crafted for sharing?
-
$CLOV If you sell this, you will kick yourself later on, ER will show 100k new members ,Board is , stick with it, this company is not going away any time soon
-
$CLOV Analysts peg this at $15+ , shorts say 5 or $6, I think everyone is going to be right before this is over
-
$CLOV I’m buying 250 more at 11am to beat the rush
-
Let’s go...
-
taking off
-
$CLOV Hindenburg says in the report -“Our report highlighted that a Clover subsidiary called Seek Insurance was misleading seniors by claiming to offer “independent” and “unbiased” advice on selecting Medicare plans.
It’s just ironic that Hindenburg claims to give independent unbiased advice for $CLOV, but someone is picking this stock to write about and someone is paying for these reports(🩳) -
$CLOV Trading in the low 9’s, I have never heard of a Wallmart sales agreement making a stock go down, I donT think the price is an accurate reflection of the value at this point, still a buy
-
$CLOV Price has bottomed out for today. Brighter days ahead after this weakness️
-
$CLOV I don’t understand why you have to be so mean to the shorts, they are real people too